Abstract
Radiation therapy, a mainstay for anti-tumor therapeutic regimens for a variety of tumor types, triggers tumor cell apoptotic pathways by either directly eliciting DNA damage or indirectly inducing the formation of oxygen radicals. In an effort to augment radiation therapy, we generated a double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus (Ad−ΔE1B19/55). In combination with radiotherapy, greater cytotoxicity was observed for Ad−ΔE1B19/55 than for the single E1B 55 kDa-deleted oncolytic Ad (Ad−ΔE1B55). Consistent with this observation, higher levels of p53, phospho-p53, phospho-Chk1, phospho-Chk2, PI3K (phosphatidylinositol-3-kinase), phospho-AKT, cytochrome c, and cleavage of PARP (poly (ADP-ribose) polymerase) and caspase-3 were observed in cells treated with Ad−ΔE1B19/55 compared with those treated with Ad−ΔE1B55, indicating that the E1B 19 kDa present in Ad−ΔE1B55 may partially block radiation-induced apoptosis. A significant therapeutic benefit was also observed in vivo when oncolytic Ads and radiation were combined. Tumors treated with Ad−ΔE1B19/55 and radiation showed large areas of necrosis and apoptosis with the corresponding induction of p53. Finally, consistent with in vitro observations, the combination of Ad−ΔE1B19/55 and radiation was more efficacious than the combination of Ad−ΔE1B55 and radiation. Taken together, these results present a strong therapeutic rationale for combining radiation therapy with E1B 19 kDa-deleted oncolytic Ad.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
O'Shea CC, Johnson L, Bagus B, Choi S, Nicholas C, Shen A et al. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity. Cancer Cell 2004; 6: 611–623.
Dilley J, Reddy S, Ko D, Nguyen N, Rojas G, Working P et al. Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity. Cancer Gene Ther 2005; 12: 715–722.
Idema S, Lamfers ML, van Beusechem VW, Noske DP, Heukelom S, Moeniralm S et al. AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy. J Gene Med 2007; 9: 1046–1056.
Freytag SO, Barton KN, Brown SL, Narra V, Zhang Y, Tyson D et al. Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer. Mol Ther 2007; 15: 1600–1606.
Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Lecluse Y et al. Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. Br J Cancer 2003; 89: 577–584.
Rogulski KR, Freytag SO, Zhang K, Gilbert JD, Paielli DL, Kim JH et al. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy. Cancer Res 2000; 60: 1193–1196.
Portella G, Pacelli R, Libertini S, Cella L, Vecchio G, Salvatore M et al. ONYX-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells. J Clin Endocrinol Metab 2003; 88: 5027–5032.
Freytag SO, Rogulski KR, Paielli DL, Gilbert JD, Kim JH . A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy. Hum Gene Ther 1998; 9: 1323–1333.
Yu DC, Chen Y, Dilley J, Li Y, Embry M, Zhang H et al. Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel. Cancer Res 2001; 61: 517–525.
Lamfers ML, Grill J, Dirven CM, Van Beusechem VW, Geoerger B, Van Den Berg J et al. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy. Cancer Res 2002; 62: 5736–5742.
Chen Y, DeWeese T, Dilley J, Zhang Y, Li Y, Ramesh N et al. CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity. Cancer Res 2001; 61: 5453–5460.
Freytag SO, Stricker H, Pegg J, Paielli D, Pradhan DG, Peabody J et al. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res 2003; 63: 7497–7506.
Boyd JM, Malstorm S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B et al. Adenovirus E1B 19kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994; 79: 341–351.
Chiou SK, Tseng CC, Rao L, White E . Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J Virol 1994; 68: 6553–6566.
Huang DC, Cory S, Strasser A . Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 1997; 14: 405–414.
Yoon AR, Kim JH, Lee YS, Kim H, Yoo JY, Sohn JH et al. Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin. Hum Gene Ther 2006; 17: 379–390.
Kim J, Cho JY, Kim JH, Jung KC, Yun CO . Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy. Cancer Gene Ther 2002; 9: 725–736.
Belikova NA, Jiang J, Tyurina YY, Zhao Q, Epperly MW, Greenberger J et al. Cardiolipin-specific peroxidase reactions of cytochrome C in mitochondria during irradiation-induced apoptosis. Int J Radiat Oncol Biol Phys 2007; 69: 176–186.
Billis W, Fuks Z, Kolesnick R . Signaling in and regulation of ionizing radiation-induced apoptosis in endothelial cells. Recent Prog Horm Res 1998; 53: 85–92; discussion 93.
Vladimirov Iu A, Klebanov GI, Borisenko GG, Osipov AN . [Molecular and cellular mechanisms of the low intensity laser radiation effect]. Biofizika 2004; 49: 339–350.
Mason KA, Neal R, Hunter N, Ariga H, Ang K, Milas L . CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors. Radiother Oncol 2006; 80: 192–198.
Milas L, Fujii T, Hunter N, Elshaikh M, Mason K, Plunkett W et al. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res 1999; 59: 107–114.
Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N et al. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Cancer Res 2001; 61: 6428–6436.
Portella G, Scala S, Vitagliano D, Vecchio G, Fusco A . ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines. J Clin Endocrinol Metab 2002; 87: 2525–2531.
Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000; 6: 879–885.
Kolesnick R, Fuks Z . Radiation and ceramide-induced apoptosis. Oncogene 2003; 22: 5897–5906.
Sherr CJ, McCormick F . The RB and p53 pathways in cancer. Cancer Cell 2002; 2: 103–112.
Yun CO, Kim E, Koo T, Kim H, Lee YS, Kim JH . ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis. Cancer Gene Ther 2005; 12: 61–71.
Kim JH, Lee YS, Kim H, Huang JH, Yoon AR, Yun CO . Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J Natl Cancer Inst 2006; 98: 1482–1493.
Chu RL, Post DE, Khuri FR, Van Meir EG . Use of replicating oncolytic adenoviruses in combination therapy for cancer. Clin Cancer Res 2004; 10: 5299–5312.
Kim J, Kim JH, Choi KJ, Kim PH, Yun CO . E1A- and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects. Hum Gene Ther 2007; 18: 773–786.
Zhang M, Li S, Li J, Ensminger WD, Lawrence TS . Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts. Mol Ther 2003; 8: 21–28.
Qian J, Yang J, Dragovic AF, Abu-Isa E, Lawrence TS, Zhang M . Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2. Cancer Res 2005; 65: 5493–5497.
Simons JW, Marshall FF . The future of gene therapy in the treatment of urologic malignancies. Urol Clin North Am 1998; 25: 23–38.
Jereczek-Fossa BA, Marsiglia HR, Orecchia R . Radiotherapy-related fatigue. Crit Rev Oncol Hematol 2002; 41: 317–325.
Jereczek-Fossa BA, Marsiglia HR, Orecchia R . Radiotherapy-related fatigue: how to assess and how to treat the symptom. A commentary. Tumori 2001; 87: 147–151.
Post DE, Khuri FR, Simons JW, Van Meir EG . Replicative oncolytic adenoviruses in multimodal cancer regimens. Hum Gene Ther 2003; 14: 933–946.
Acknowledgements
This work was supported by grants from the Ministry of Commerce, Industry and Energy (10030051, Dr C-O Yun), the Korea Science and Engineering Foundation (KOSEF) (R04-2004-000-10011-0, R01-2006-000-10084-0, R15-2004-024-02001-0, M10416130002-04N1613-00210, Dr C-O Yun), and through its National Nuclear Technology Program. Jaesung Kim, Ji Young Yoo and A-Rum Yoon are graduate students sponsored by the Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea. Pyung-Hwan Kim is a graduate student sponsored by the graduate program for Nanomedical Science, Yonsei University, Seoul, South Korea.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Gene Therapy website (http://www.nature.com/gt)
Supplementary information
Rights and permissions
About this article
Cite this article
Kim, J., Kim, PH., Yoo, J. et al. Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect. Gene Ther 16, 1111–1121 (2009). https://doi.org/10.1038/gt.2009.72
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2009.72
Keywords
This article is cited by
-
CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo
Blood Cancer Journal (2014)
-
The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model
Cancer Gene Therapy (2013)
-
The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma
Gene Therapy (2012)
-
Molecular characterization of apoptosis induced by CARF silencing in human cancer cells
Cell Death & Differentiation (2011)